AJK Biopharmaceutical
AJK Biopharmaceutical is a biotechnology company that researches and develops novel anti-infective drugs.
Industries
biotechnology
medical
pharmaceutical
Nr. of Employees
small (1-50)
AJK Biopharmaceutical
Irvine, California, United States, North America
Products
Broad-Spectrum Antimicrobial Cyclic Peptides
Cyclic peptides designed to act against multi-drug resistant bacteria, fungi, and viruses by disrupting microbial membranes.
Antiviral Peptides Against SARS-CoV-2, HSV, and HPV
Peptides developed to inhibit viral infections including SARS-CoV-2, herpes simplex virus, and human papilloma virus.
Antifungal Peptides for Onychomycosis
Peptides targeting fungal infections, specifically designed to treat onychomycosis (nail fungal infections).
Cyclic Peptide Platform for Therapeutic Macromolecule Delivery
A platform technology using cyclic peptides to facilitate the delivery of nucleic acids and proteins into cells.
Broad-Spectrum Antimicrobial Cyclic Peptides
Cyclic peptides designed to act against multi-drug resistant bacteria, fungi, and viruses by disrupting microbial membranes.
Antiviral Peptides Against SARS-CoV-2, HSV, and HPV
Peptides developed to inhibit viral infections including SARS-CoV-2, herpes simplex virus, and human papilloma virus.
Antifungal Peptides for Onychomycosis
Peptides targeting fungal infections, specifically designed to treat onychomycosis (nail fungal infections).
Cyclic Peptide Platform for Therapeutic Macromolecule Delivery
A platform technology using cyclic peptides to facilitate the delivery of nucleic acids and proteins into cells.